HER-2 B cell epitope peptide-based cancer vaccines and combination immunotherapies with EGFR, HER-3, IGF-1R, VEGF and a therapeutic combination vaccine of PD-1 and HER-2

09/05/2018 15:00h.

Lugar: Sala Marie Curie

Tipo evento: Sesiones científicas

Ponentes: Pravin T. P. Kaumaya

Organizador: Departament CEXS, UPF

Volver

Documentos: